Aphios Receives Frost & Sullivan Best Practices Award

Published: Dec 08, 2009

WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced that it is the proud recipient of the 2009 Frost & Sullivan North American Excellence in Healthcare Technology Innovation of the Year Award in the field of Enhanced Nanodrug Therapeutic Systems for developing the SuperFluids™ nanodrug solubility, encapsulation and delivery platforms. These platforms are unique in that they create dense phase super solvents with superior thermodynamic properties, allowing them to formulate and deliver drugs to targets that are not resolvable through conventional means.

Back to news